🇺🇸 Riboflavin Sodium Phosphate Injection in United States

5 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 5

Most-reported reactions

1. Alcohol Poisoning — 1 report (20%)
2. Brain Stem Infarction — 1 report (20%)
3. Fall — 1 report (20%)
4. Movement Disorder — 1 report (20%)
5. Muscular Weakness — 1 report (20%)

Source database →

Frequently asked questions

Is Riboflavin Sodium Phosphate Injection approved in United States?

Riboflavin Sodium Phosphate Injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Riboflavin Sodium Phosphate Injection in United States?

Xijing Hospital of Digestive Diseases is the originator. The local marketing authorisation holder may differ — check the official source linked above.